Announced
Completed
Financials
Sources
Tags
Acquisition
Majority
Completed
Single Bidder
Switzerland
allergy treatment
Health Care Services
Cross Border
Disposal
Private
Friendly
Synopsis
Stallergenes Greer, a biopharmaceutical company, completed the acquisition of Palforzia business from Nestlé, a multinational food and drink processing company. Financial terms were not disclosed. "We are confident that Stallergenes Greer will take Palforzia forward and ensure this unique treatment supports patients around the world. At the same time, the divestiture allows Nestlé Health Science to focus on its core strengths and key growth drivers," Greg Behar, Nestlé Health Science CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.